Articles

Medicine Quality Monitoring Globe

My Journey to Becoming a QPPV in Ghana

Educational Materials for PV Education at Universities

Establishing Malawi's PV Centre: My Career In Pharmacovigilance

ISoP Mid-Year Training Course 2019 - A Report

Social Media as a Pharmacovigilance Tool in Africa

My pharmacovigilance journey as an Industrial Engineering PhD student

My Pharmacovigilance Journey – A Masters Student’s Perspective

Spontaneous Reporting

My Pharmacovigilance Journey

Sharing expertise and collating information to increase understanding of poor quality medicines globally

Newton workshop to build data management skills and network for early career researchers

Responding to the growing mandate for researchers to share their clinical data, WWARN is joining with partners to host a 3-day workshop in January sponsored by the British Council’s Newton Researcher Links Programme in order to develop the skills and network needed to produce high quality data capable of maximising the impact of initial findings.

The patient's ‘voice’ in pharmacovigilance

FIGO's updated recommendations for misoprostol used alone in gynecology and obstetrics

In 2012, the International Federation of Obstetrics and Gynecology (FIGO) produced a chart detailing recommended dosages of misoprostol when used alone, for a variety of obstetric and gynecologic indications. In light of new evidence and through expert deliberation, this chart has now been revised and expanded. The present commentary explain the changes and the decisions made. 

Cups or Cash for Girls (CCg) Trial in Western Kenya

The Cups or Cash for Girls (CCg) Trial is currently being conducted in Western Kenya. This trial is investigating whether giving school girls a menstrual cup, cash transfer, or both, has an impact on various deleterious outcomes. This trial offers a unique perspective on safety monitoring and this article discusses why safety monitoring is important in such a trial and how it is being tackled.

Pharmacovigilance in pregnancy

Cochrane Adverse Effects Methods Group Webinar on How to Overcome the Challenge of Reviewing Adverse Effects

The Cochrane Adverse Effects Methods Group presented a webinar on 'How to Overcome the Challenges of Reviewing Adverse Effects'. View an edited version of this webinar or download the slides.

DSMBs and clinical trial safety

The Data Safety and Monitoring Board (DSMB) or Data Monitoring Committee (DMC – these are synonymous terms) is a group of individuals put together by the sponsor or CRO (if contracted out) with relevant expertise to carry out the important role of monitoring the safety of a clinical trial study.

Building Teratovigilance Capacity in Africa

Genome-wide association study of nevirapine hypersensitivity in a sub-Saharan African HIV-infected population

Trying to identify genetic biomarkers of nevirapine hypersensitivity.